Global Lung Disease Therapeutics Market to Reach US$106.9 Billion by 2030, Driven by Rising Respiratory Illnesses and Treatment Innovations
The market for pharmaceuticals and therapies used to control and treat respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary …